2025年2月26日 · Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine …

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. A leader in essential plasma-derived medicines and transfusion …

We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the first analysis laboratory in Barcelona: Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos.

At Grifols, we are pioneers in the development of therapies derived from blood and plasma. We contribute to building the future of healthcare to improve people's well-being. Since 1909, we …

Grifols es una compañía global líder en el sector de la salud. Nuestros innovadores medicamentos derivados del plasma, otros productos biofarmacéuticos y soluciones en …

Grifols treatments center on immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. Each area features therapies helping patients …

Grifols USA was established in 2003. Based in Los Angeles, we cover the U.S. market where we offer a comprehensive portfolio of Grifols products and services. The company is one of the …

2025年2月18日 · In 2023, Grifols launched its AlphaID™ At Home service, enabling U.S. adults to screen for the genetic risk of AAT deficiency without prescription from a healthcare …

Grifols is a global healthcare company with more than 75 years of history improving the health and well-being of people around the world. We produce essential plasma medicines for …

2025年2月25日 · Following the recent Capital Markets Day on 27 Feb 2025, Grifols announces it will hold a Non-Deal Roadshow (NDR) for equity investors during the week of March 17th, …